Why it mattersThe funding round signals sustained private capital confidence in specialized AI infrastructure outside traditional hyperscalers, with major institutions like Jane Street betting billions on Crusoe's ability to meet surg…
The round came together after the data center developer reportedly secured a $13 billion contract with Jane Street.
By Chella·1d ago
Why it mattersOpenAI’s latest agent swarm incident adds urgency to calls for independent investigations as researchers and lawmakers question whether AI labs should control the scope of their own safety reviews.
By Chella·5h ago
Why it mattersNscale, which recently struck a $45 billion deal with Anthropic, is in talks to raise additional funds in anticipation of an upcoming IPO.
By Chella·7h ago
Why it mattersOther archives and libraries around the world may also contain genetic traces of past disease outbreaks.
By Chella·9h ago
Why it mattersGoPro CEO Nick Woodman said in a letter to customers that making cameras is still his company's "core DNA," after a proposed $285 million acquisition by Starman was announced earlier this week. He claims the merger puts …
GoPro CEO Nick Woodman said in a letter to customers that making cameras is still his company's "core DNA," after a proposed $285 million acquisition by Starman…
By Chella·10h ago
Why it mattersApple's September 9th launch event could be one of its biggest in years. It will be Apple's first event since John Ternus took over as CEO on September 1st, stepping in for Tim Cook, and will likely feature the first mod…
Apple's September 9th launch event could be one of its biggest in years. It will be Apple's first event since John Ternus took over as CEO on September 1st, ste…
By Chella·13h ago
Why it mattersNvidia's decision to widen DLSS 5 access to older hardware could democratize advanced gaming performance, but the company's restrictions on developer customization may limit innovation in how the AI rendering technology …
Officially, Nvidia's controversial DLSS 5 AI rendering was supposed to launch this evening with only a single game, only on Nvidia's latest RTX 50 GPUs, and wit…
By Marcus·1d ago
Why it mattersThe latest pharma news from the Pharmalot campus brought to you by the Pharmalittle newsletter
By Chella·15h ago
Why it mattersA closely watched cardiovascular drug from Novartis failed in a pivotal study, the company said Friday, a major blow to the firm.
By Chella·7h ago
Why it mattersThe biggest barrier for a top schzophrenia treatment, Ionis' first approval for Alexander disease, and more biotech news
By Chella·15h ago
Why it mattersNaloxone and harm reduction measures may be helping to curb drug overdose deaths, a new report says.
By Chella·2d ago
Why it mattersZanvastro is the first disease-modifying treatment for Alexander disease, a rare and fatal disorder.
By Chella·1d ago